Articles

Aged 17-24? Consider a Paid Internship with Gatehouse ICS

Based in Ammanford, South Wales, we are committed to working with those looking for the next step on their career path. A paid internship could be a great move for you.

Read More
Is Market Research an Appropriate Channel for Adverse Event Data Collection?

Is Market Research an Appropriate Channel for Adverse Event Data Collection?

Glyn Griffiths looks at whether the benefit of catching a few adverse events outweighs the reduced ability tocollect accurate data.

Read More
Why the Payer Perpective is Important in Due Diligence

Why the Payer Perspective is Important in Due Diligence

When taking into account clinician, patient and market perspectives as part of due diligence, the payer perspective can often be overlooked. Christie Harper discusses why this is a problem.

Read More

Payer Research in the New NHS

The NHS is going through substantial change. Christie Harper looks at the new opportunities to amplify messaging beyond one hospital to an entire region.

Read More
Christie Harper explains how the GDPR does not prevent collection of relevant data regarding clinicians and payers, as long as over-arching criteria are met.

Managing GDPR Obligations in Payer and Clinician Research

Christie Harper explains how the GDPR does not prevent collection of relevant data regarding clinicians and payers, as long as over-arching criteria are met.

Read More

Why You Are More Than Your Bandwidth: Bringing your whole self to the workplace

Looking beyond merely assesing your employees as a unit of value. Christie Harper chats about why her employees and their relationships are considered to be important.

Read More
Do You Know the Market Opportunity for Your New Life Sciences Asset?

Do You Know the Market Opportunity for Your New Life Sciences Asset?

Christie Harper discusses the importance of understanding how your asset fits into the market, including asking if investment in it is even a good idea.

Read More

Take Time to Smell the Roses: Building a flexible, socially engaged workplace

Following on from her previous article, Christie Harper discusses going beyond our To Do lists and expanding our day to involve social interaction.

Read More
The Pros and Cons of Digital Apps in the Complex NHS Landscape

The Pros and Cons of Digital Apps in the Complex NHS Landscape

Sarah Jones considers the growing push towards adopting and gaining insights from digital solutions and applications.

Read More

Stop Racing the Clock: Tips for a healthier approach to project management

Christie Harper looks at ways to improve our approach to project management that doesn't involve just being governed by time restrictions.

Read More
Working with the NHS in the Age of Covid and Holistic Restructuring

Working with the NHS in the Age of Covid and Holistic Restructuring

Sarah Jones looks at the way that Covid has challenged widely held preconceptions, and the NHS has become incredibly agile.

Read More
Defining what makes your health economics consultancy different

Don’t rest on your laurels: Defining what makes your market access consultancy different

Christie harper takes time to discuss why you shouldn't rest on your laurels and the importance of defining what makes your market access consultancy different.

Read More
Why business development matters now more than ever to life sciences consultancies

Why business development matters more than ever to life sciences consultancies

Christie Harper looks at how to tailor your business development to cope with the current recession having a lagged effect on the pharmaceutical industry.

Read More
Why the next recession could hit health economic consultancies harder

Why the next recession could hit health economic consultancies harder

Christie Harper sheds some light on this matter, including the fact that consultancies are operating in a false economy, still working from pharma budgets set pre-Covid.

Read More
Who is doing what in data and digital tools in HEOR and market access?

Consultancies: How did your booth messaging stack up versus competitors at ISPOR Europe 2019.

Digital and Data were the most common descriptors on exhibitor booths at ISPOR Europe 2019; but who is doing what in data and digital tools in HEOR and market access?

Read More
Is it still good return on investment for consultancies to have a booth at ISPOR?

Is it still good return on investment for consultancies to have a booth at ISPOR?

Christie Harper speaks from 18 years experience attending ISPOR in various consultancy roles

Read More
Selling consultancy services to pharma

Is this the perfect model for selling consultancy services to pharma?

Christie Harper looks at historical trends in sales models and puts forward a case for Insight Selling as the perfect fit for selling in this industry.

Read More
Grant funding for RAISE Wales CIC

Grant funding awarded to support feasibility stage of RAISE Wales CIC

Christie Harper summarises the plans for RAISE Wales CIC which has just been awarded funding from the IDEAS & Pioneers Fund from the Paul Hamlyn Foundation.

Read More
Upcoming UK digital health events

28 Upcoming UK digital health events that may not be on your radar

Hope Price has compiled this list of events for all you UK-based digital health innovators, gurus or interested onlookers!

Read More
Value communication consultancies word cloud

Are value communication consultancies good at communicating their own value?

Hope Price investigates the value messaging communicated by HEOR, Market Access, value & med comms consultancies around ISPOR Europe 2018

Read More
Consultancy based selling and strawberry cheesecake

What do consultancy based selling and strawberry cheesecake have in common?

Christie Harper discusses an approach to empowering consultants and researchers to sell their services to the pharmaceutical, medical device and biotech industries.

Read More
Woman looking up from microscope

Look Up! Shifting focus from development of your health innovation to the likelihood of its NHS adoption

Christie Harper discusses a number of factors tht may influence NHS acceptability of a health innovation, even when the benefits seem obvious at pre-implementation stage.

Read More